Pfizer hosts Patients in Focus summit and renews its commitment to patient well-being

As part of its commitment to patient well-being, a pharmaceutical and biotechnology company, Pfizer, hosted the second annual Patients in Focus summit on Friday.

The theme of the summit, "with patients, for patients", is an interactive panel discussion with the society's Country Director for West Africa, Olayinka Subair, and oncology patient advocates, rare diseases and vaccination who shared the impacts of their interventions on patients.

According to Subair, the virtual event aims to learn from the company's patient advocacy partners to understand and better integrate patient voices into our daily work.

ALSO READ FROM NIGERIAN TRIBUNE

He said, "Pfizer could not achieve its goal without the central role played by patients, caregivers and advocates, whether by engaging in research and development efforts, offering design advice clinical trials, or by partnering with us to develop easy-to-understand tools, resources and materials for our patients.

“This time and focus will support our work as we continue to strive to be the most patient-centric company, understanding and integrating the patient perspective into everything we do. , Pfizer will be able to develop more innovative medicines and breakthroughs when we engage with patients and patient advocacy groups to understand the needs of all patients.

"Patients in Focus stimulates inspiration, energy and innovation by showcasing examples of new ways to include patients at every stage of Pfizer's work and is an opportunity for us to collectively consider how we we can continue to better meet the changing needs of patients in the years to come."

Pfizer's Director of Corporate Affairs, Sally Susman, said Pfizer's goal is to develop breakthroughs that change the lives of patients.

She said, "For our work to be meaningful, every function at Pfizer must understand the importance of involving patients, caregivers and advocates in our work. By showcasing real patient experiences and where we have had an impact on patients' lives, Patients in Focus week will continue to build empathy and show our colleagues how to focus on patient advocacy throughout the year and in everything we do."

In their separate submissions, patient advocates highlighted the impact of partnerships and the importance of including patient perspectives in all facets of Pfizer's work.

Vice President, Global Access Financing, Michelle Akande, said, "Patients in Focus allows us to highlight and learn from examples of successful patient engagement and partnerships, demonstrating not only how Pfizer has made a difference in the lives of patients, but how patient groups provide information that guides our work.

"By sharing the real experiences of patients and caregivers, Patients in Focus will build empathy and enable colleagues to better understand patient journeys and how we can work with patients to address unmet needs. Patients in Focus Focus enables us to showcase two-way advocacy relationships and partnerships that build trust and increase awareness of the value and benefits of partnering with patients across all functions.”

A clinical psychologist and executive director of Rare Disease Ghana Initiative, Samuel Agyei Wiafe, revealed that more than 7,000 diseases have been identified.

According to him, Rare Disease Ghana Initiative, in collaboration with Pfizer, has been able to fill the gaps in the management of these diseases, ranging from increased knowledge and awareness to early diagnosis and prevention, through best practices in treatment and care to the community. commitment to access to the best treatments and thorough research.

Leah Foundation Medical Director Dr. Oyinloye commented: "Collaborating with Pfizer has allowed us to bridge the care gap with cancer treatment, as we are able to offer consultation and assessments, counselling, sensitization and sensitization campaigns through road trips, Radio Jingles in the North Central Axis of Nigeria.”

The Vaccine Network for Disease Control Programs Manager, Chika Nwankwo, said, “The Vaccine Network for Disease Control and Pfizer have a long history of working together to address relevant issues of community outreach through edutainment. This community awareness campaign approach has since been adopted by many health services and has achieved positive results in transforming community behaviors around vaccines and other health services in Nigeria.”